Title: Angélica Kloberg - Innovator in Neurological and Psychiatric Treatments.
Introduction
Angélica Kloberg is an inventor based in Torslanda, Sweden. He is currently associated with A. Carlsson Research AB. Although he has not yet been granted any patents, his work focuses on significant advancements in the treatment of neurological and psychiatric disorders.
Latest Patent Applications
Angélica Kloberg's notable patent application is titled "Phenylpiperidine Compounds for the Treatment of Neurological and Psychiatric Disorders." This invention relates to the novel use of both enantiomers of the phenylpiperidine derivative OSU6162, specifically (−) and (+)-OSU6162, as partial agonists on 5-hydroxytryptamine (5-HT) receptors. The application highlights that both enantiomers may be utilized for the treatment and/or prevention of diseases associated with the modulation of monoaminergic neurotransmitter receptors. This includes the stabilization of dopaminergic and serotonergic brain signaling, acting as partial agonists on such receptors.
Conclusion
Angélica Kloberg is making strides in the field of neurological and psychiatric treatment through his innovative research and patent applications. His contributions may lead to significant advancements in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.